|
|
Line 39: |
Line 39: |
| ===2021: [https://www.ingentaconnect.com/contentone/png/ajhb/2021/00000045/00000003/art00004#expand/collapse Switching away from Cigarettes across 12 Months among Adult Smokers Purchasing the JUUL System]=== | | ===2021: [https://www.ingentaconnect.com/contentone/png/ajhb/2021/00000045/00000003/art00004#expand/collapse Switching away from Cigarettes across 12 Months among Adult Smokers Purchasing the JUUL System]=== |
| *Rates of switching with JUUL increased over time. Over 50% of respondents reported complete switching away from cigarettes 12 months following purchase. Greater use of and dependence on JUUL predicted switching. | | *Rates of switching with JUUL increased over time. Over 50% of respondents reported complete switching away from cigarettes 12 months following purchase. Greater use of and dependence on JUUL predicted switching. |
| | |
| | ===2021: [https://academic.oup.com/ntr/advance-article/doi/10.1093/ntr/ntab148/6322566 Reappraising Choice in Addiction: Novel Conceptualizations and Treatments for Tobacco Use Disorder]=== |
| | *Given the advent of novel, alternative tobacco products, Tobacco Use Disorder must be conceptualized within a contemporary framework that includes harm reduction and alternative outcomes. |
| | *[https://academic.oup.com/ntr/advance-article-pdf/doi/10.1093/ntr/ntab148/39068104/ntab148.pdf PDF Version] |
|
| |
|
| ===2021: [https://pubmed.ncbi.nlm.nih.gov/34002223/ Differences in Switching Away From Smoking Among Adult Smokers Using JUUL Products in Regions With Different Maximum Nicotine Concentrations: North America and the United Kingdom]=== | | ===2021: [https://pubmed.ncbi.nlm.nih.gov/34002223/ Differences in Switching Away From Smoking Among Adult Smokers Using JUUL Products in Regions With Different Maximum Nicotine Concentrations: North America and the United Kingdom]=== |